Company / EPS (Basic)
Genprex, Inc. EPS (Basic) History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$22.56
FY2024
5-year range
-$22.56 / -$0.44
FY2022-FY2024
Trend
-13.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.44 to $-22.56 over the past 2 years.
Based on SEC 10-K filings.
-22.56 in FY2024.
Declined from $-0.44 to $-22.56 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, eps (basic) decreased 13.9% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -24.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$22.56 | -13.9% |
| FY2023 | -$19.80 | -4400.0% |
| FY2022 | -$0.44 | - |
| FY2021 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026